Briacell Therapeutics
Quarterly Financials
| Values in thousands | 2025-10-31 | 2025-07-31 | 2025-04-30 | 2025-01-31 |
|---|---|---|---|---|
Revenue | $0 | $225 | $0 | $0 |
Gross Profit | -36 | -36 | -37 | -38 |
EBITDA | -11,449 | -11,120 | -8,765 | -9,091 |
EBIT | -11,486 | -11,156 | -8,803 | -9,129 |
Net Income | -11,374 | -11,057 | -8,716 | -9,062 |
Net Change In Cash | 0 | 225 | 0 | 0 |
Free Cash Flow | -10,690 | -11,203 | -10,105 | -8,551 |
Cash | 2,714 | 14,428 | 17,215 | 7,389 |
Basic Shares | 1,883 | 1,883 | 1,867 | 2,699 |
Annual Financials
| Values in thousands | 2024-07-31 | 2023-07-31 | 2022-07-31 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
Gross Profit | -114 | -20 | -19 |
EBITDA | -6,624 | -27,247 | -34,106 |
EBIT | -6,738 | -27,267 | -34,125 |
Net Income | -6,547 | -27,267 | -34,126 |
Net Change In Cash | 0 | 0 | 0 |
Cost of Revenue | -16,227 | ||
Free Cash Flow | -33,592 | -31,891 | -15,874 |
Cash | 1,196 | 28,381 | 52,634 |
Basic Shares | 1,096 | 1,041 | 1,032 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-10-31 | -$4.35 |
2025-07-31 | -$9.24 |
2025-04-30 | -$1.64 |
2025-01-31 | -$2.33 |
